18 / 88
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 4, July/August 2017
220
AFRICA
The echocardiographic features had evolved to greater leaflet
thickening, calcification and reduced motion with very little
prolapse. These findings may have significant implications for
the current management of rheumatic mitral valve disease and
contribute to better understanding of the evolution from acute
to chronic rheumatic heart disease.
R Meel was the recipient of the Carnegie PhD Fellowship award (Carnegie
Corporation grant no. b8749.r01).
References
1.
Essop MR, Nkomo V. Rheumatic and non-rheumatic valvular heart
disease. Epidemiology, management, and prevention in Africa.
Circulation
2005;
112
: 3584–3591. [PMID: 16330700].
2.
Enriquez-Sarano M, Akins C W, Vahanian A. Mitral regurgitation.
Lancet
2009;
373
: 1382–1394. [PMID: 19356795].
3.
Adams A, Rosenhek R. Degenerative mitral valve regurgitation: best
practice revolution.
Eur Heart J
2010;
31
: 1958–1967. [PMID: 20624767].
4.
Essop MR, Peters F. Contemporary issues in rheumatic fever and
chronic rheumatic heart disease.
Circulation
2014;
130
: 2181–2188.
[PMID: 25602946].
5.
Stewart S, Wilkinson D, Hansen C,
et al
. Predominance of heart
failure in the heart of Soweto study cohort: emerging challenges for
urban African communities.
Circulation
2008;
118
: 2360–2367. [PMID:
19029467].
6.
Marcus RH, Sareli P, Pocock WA,
et al
. The spectrum of severe rheu-
matic mitral valve disease in a developing country. Correlations among
clinical presentation, surgical pathologic findings, and hemodynamic
sequelae.
Ann of Inter Med
1994;
120
: 177–183. [PMID: 8043061].
7.
Dajani A, Ayoub E, Bierman F,
et al
. Special writing committee on
rheumatic fever, endocarditis and Kawasaki disease of the Council
on Cardiovascular Disease in the young of the American Heart
Association. Guidelines for the diagnosis of rheumatic fever, Jones
criteria, 1992 update.
J Am Med Assoc
1992;
26
8: 2069–2073. [PMID:
1404745].
8.
World Health Organisation. Rheumatic fever and rheumatic heart
disease.
World Health Org Tech Rep
Ser
2001;
923
: 1–122. [PMID:
15382606].
9.
Lang RM, Badano LP, Mor-Avi V,
et al.
Recommendations for cardiac
chamber quantification by echocardiography in adults: an update
from the American Society of Echocardiography and the European
Association of Cardiovascular Imaging.
Eur Heart J Cardiovasc Imag
2015;
16
: 233–270. [doi: 10.1093/ehjci/jev014].
10. Nagueh SF, Appleton CP, Gillebert TC,
et al
. Recommendations for the
evaluation of left ventricular diastolic function by echocardiography
.
Eur J Echocardiogr
2009;
10
: 165–193. [PMID: 19270053].
11. Rudski LG, Lai WW, Afilalo J,
et a
l. Guidelines for the echocar-
diographic assessment of the right heart in adults: a report from the
American Society of Echocardiography endorsed by the European
Association of Echocardiography, a registered branch of the European
Society of Cardiology, and the Canadian Society of Echocardiography.
J Am Soc Echocardiogr
2010;
23
: 685–713. [http://.dx.doi: 10.1016/j.
echo.2010.05.010].
12. Lancellotti P, Moura L, Pierard LA,
et al
. European Association of
Echocardiography recommendations for the assessment of valvular
regurgitation. Part 2: mitral and tricuspid regurgitation (native valve
disease).
Eur J Echocardiogr
2010;
11
: 307–332. doi: 10.1093/ejechocard/
jeq031.
13. Reményi B, Wilson N, Steer A,
et al
. World Heart Federation criteria for
echocardiographic diagnosis of rheumatic heart disease – an evidence-
based guideline.
Nat Rev Cardiol
2012;
28
: 297–309. [http://.dx.doi:
10.1038/nrcardio.2012.7].
14. Chauvaud S, Fuzellier J, Berrebi A,
et al
. Long-term (29 years)
results of reconstructive surgery in rheumatic mitral valve insufficiency.
Circulation
2001;
104
(12 Suppl 1): I12–5. [PMID: 11568022].
15. Wilkins GT, Weyman AE, Abascal VM,
et al.
Percutaneous balloon
dilatation of the mitral valve: an analysis of echocardiographic variables
related to outcome and the mechanism of dilatation.
Br Heart J
1988;
60
: 299–308. [PMID: 3190958].
16. Cilliers A. Rheumatic fever and rheumatic heart disease in Gauteng on
the decline: Experience at Chris Hani Baragwanath Academic Hospital,
Johannesburg, South Africa.
S Afr Med J
2014;
104
: 632–634. [http://.
dx.doi: 10.7196/samj.8318].
17. Engel ME, Haileamlak A, Zühlke L,
et al
. Prevalence of rheu-
matic heart disease in 4720 asymptomatic scholars from South Africa
and Ethiopia.
Heart
2015;
10
1: 1389–1394
.
[http://.dx.
doi: 10.1136/
heartjnl-2015-307444].
18. Zühlke L, Engel ME, Karthikeyan G,
et al
. Characteristics, complica-
tions, and gaps in evidence-based interventions in rheumatic heart
disease: the Global Rheumatic Heart Disease Registry (the REMEDY
study).
Eur Heart J
2015;
36
: 1115–1122. [http://.dx. doi: 10.1093/
eurheartj/ehu449].
19. Choudhary S, Talwar S, Dubey B,
et al
. Mitral valve repair in a predom-
inantly rheumatic population: long-term results.
Tex Heart Inst J
2001;
28
: 8–15. [PMCID: PMC101122].
20. Antunes M, Barlow JB. Management of tricuspid valve regurgitation
.
Heart
2007;
93
: 271–276. [PMID: 17228081].